provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content

Tysabri

natalizumab
Used for Crohn's Disease, Multiple Sclerosis
Used for Crohn's Disease, Multiple Sclerosis

Tysabri (natalizumab) treats relapsing forms of multiple sclerosis (MS) and moderate-to-severe Crohn's disease (CD) in adults. This medication is a monoclonal antibody that works as an integrin antagonist. It lowers the immune system's activity and lessens inflammation. Tysabri (natalizumab) is given by a healthcare professional as a once-monthly infusion through the vein (IV). Common side effects include headache and fatigue. Because of the risk for serious infection, your care team will help you enroll in the TOUCH Prescribing Program and review the medication's warnings before treatment starts.

Last reviewed on October 2, 2024
basics-icon

What is Tysabri (natalizumab)?

What is Tysabri (natalizumab) used for?

How Tysabri (natalizumab) works

Tysabri (natalizumab) is an integrin antagonist. It's a type of monoclonal antibody.

It's not completely known how Tysabri (natalizumab) works to treat MS and CD. But it's thought to work by attaching to a protein on immune cells called integrin. As a consequence, it blocks signals in your body that cause inflammation. This helps block inflammation from affecting your nerves (for MS) or your gut (for CD).

Drug Facts

Common BrandsTysabri
Drug ClassIntegrin receptor antagonist
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only

More on Tysabri (natalizumab) essentials

basics-icon

What are the side effects of Tysabri (natalizumab)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Other Side Effects

  • Stomach discomfort
  • Diarrhea
  • Chest discomfort
  • Muscle cramps
  • Trouble keeping your balance
  • Inflamed tonsil (tonsillitis)
  • Tooth infections
  • Herpes infection
  • Itching and pain in the vagina (vaginitis)
Note: Side effects listed were from people with multiple sclerosis. Side effects might differ slightly for people with Crohn's disease.

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Serious brain infection: weakness on one side of the body, clumsiness, confusion, changes in personality, changes in vision, difficulty remembering, difficulty thinking, headache, stiff neck, light sensitivity, seizures
  • Other infection: fever, difficulty breathing, cough, stomach pain, diarrhea, sweating, weakness, chills
  • Liver damage: nausea, vomiting, pain in the upper right side of the stomach, poor appetite, dark urine, yellowing of the skin or whites of your eyes
  • Allergic reaction or infusion reaction: hives, rash, itching, dizziness, fever, shaking, nausea, flushing, difficulty breathing, tightness in the throat, chest pain

Source: DailyMed

The following side effects have also been reported

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

Bladder pain

blistering, crusting, irritation, itching, or reddening of the skin

bloody or cloudy urine

body produces substance that can bind to drug making it less effective or cause side effects

cough

difficult, burning, or painful urination

difficulty with swallowing

dizziness

fast heartbeat

frequent, strong, or increased urge to urinate

hives, itching, skin rash

itching of the vagina or genital area

lower back or side pain

pain during sexual intercourse

passing urine more often

puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

thick, white vaginal discharge with no odor or with a mild odor

tightness in the chest

unusual tiredness or weakness

Rare

Blurred vision

changes in behavior

chest pain

confusion

difficult or labored breathing

fainting or lightheadedness when getting up suddenly from a lying or sitting position

feeling of warmth

feeling unusually cold

fever

gaseous abdominal or stomach pain

nausea

redness of the face, neck, arms, and occasionally, upper chest

shivering

sneezing

sore throat

stomach fullness

sweating

thoughts of killing oneself

yellow eyes or skin

Incidence not known

Back, leg, or stomach pains

black, tarry stools

bleeding gums

chills

dark urine

drowsiness

general body swelling

headache

heavier menstrual periods

loss of appetite

nosebleeds

pale skin

pinpoint red spots on the skin

seizures

unusual bleeding or bruising

vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Cracked, dry, scaly skin

diarrhea

difficulty with moving

discouragement

feeling sad or empty

irregular menstruation

irritability

loss of interest or pleasure

muscle pain or stiffness

pain, cramps, or heavy bleeding

pain in the joints

stomach soreness or discomfort

swollen glands

trouble concentrating

trouble sleeping

Less common

Absent, missed, or irregular menstrual periods

chest discomfort

local bleeding

shakiness in the legs, arms, hands, or feet

stopping of menstrual bleeding

trembling or shaking of the hands or feet

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

pros-and-cons

Pros and cons of Tysabri (natalizumab)

thumbs-up

Pros

Infusions are once every month

Can be used for CD or MS

Has a risk monitoring program that anyone who prescribes, dispenses, infuses, or receives the medication must enroll in to make sure it's safe for you

thumbs-down

Cons

Must be given by a healthcare professional in a healthcare setting

Infusions take about an hour

Raises your risk for serious infection

Only FDA approved for adults

pharmacist-tips

Pharmacist tips for Tysabri (natalizumab)

pharmacist
  • When you first start Tysabri (natalizumab), you'll have an appointment with your prescriber every 3 months. After you've been taking this medication for some time, you'll only need to check in every 6 months. Tysabri (natalizumab) raises the risk for serious infections because it weakens your immune system. These follow-up visits help check for any infections that might've developed during treatment.

    • Get medical help right away if you don't feel well or if you have weakness on one side of the body, changes in personality, changes in vision, fever, cough, difficulty breathing, or diarrhea. These can be signs of a serious or life-threatening infection.

      • Tell your prescriber if you're currently taking any corticosteroids (also known as steroids). Both steroids and Tysabri (natalizumab) can weaken the immune system and put you at risk for serious infections. Your prescriber will discuss with you whether to slowly lower your steroid dose over time and stop the steroid medication or stop Tysabri (natalizumab) to lower your risk for infection.

        • You can get a serious infection even after you stop taking Tysabri (natalizumab). This is because it'll take some time for your immune system to bounce back and get stronger after you stop treatment. Continue to look out for signs of infection for at least 6 months after your treatment ends.

          • If you're pregnant or thinking of becoming pregnant, talk to your prescriber to see whether Tysabri (natalizumab) is right for you. The evidence isn't completely clear. But current research suggests that there might not be a link between a higher risk of harm to an unborn baby and taking the medication during pregnancy. Discuss with your prescriber about the risks and benefits of taking the medication while pregnant.

            • Don't breastfeed while you're taking Tysabri (natalizumab) unless you've talked to your prescriber. It's not known whether breastfeeding during treatment is safe for you and your baby. Research suggests that it's expected to be safe, but you might need to wait for a certain amount of time after giving birth to breastfeed.

              faqs

              Frequently asked questions about Tysabri (natalizumab)

              How long does it take for Tysabri (natalizumab) to work?
              It's not exactly clear how long it takes for Tysabri (natalizumab) to start working for you because everyone can have a different experience with treatment. It'll probably depend on what health condition you're taking Tysabri (natalizumab) for and how severe your condition is. Studies show that the medication can start to work within 3 months for some people with multiple sclerosis and within 2 months for some people with Crohn's disease. Talk to your prescriber if you have concerns about how long it takes for Tysabri (natalizumab) to work.
              How long does the Tysabri (natalizumab) infusion take?
              It takes about an hour to infuse the entire dose of Tysabri (natalizumab) through the veins. The infusion is given by trained healthcare professionals in a clinic or infusion center. During your infusion, your care team will watch for infusion reactions in case they need to stop treatment and help manage them. These infusion reactions can include dizziness, hives, fever, nausea, and flushing. After the infusion, your care team will observe you for about another an hour to continue checking for infusion reactions.
              How long can you stay on Tysabri (natalizumab)?
              There isn't a set length of time for your treatment with Tysabri (natalizumab) for MS or CD. You'll probably continue taking the medication as long as it's helping your condition and you're not having any allergic reactions or serious side effects. In a long-term clinical study, some people with MS took Tysabri (natalizumab) for about three and a half years. But other people with MS were taking the medication for as long as almost 12 years. Make sure to regularly follow up with your prescriber so they can examine you to check how well Tysabri (natalizumab) is working for you and to address any concerning side effects. They'll discuss with you about whether your treatment plan needs any changes.
              How long does Tysabri (natalizumab) stay in your system?
              In general, it takes a little more than a month and a half for most of Tysabri (natalizumab) to leave your body after you've been taking this medication for a while. This time frame is estimated based on the half-life of Tysabri (natalizumab), which is a measure of how long it takes for your body to get rid of the medication. Talk with your prescriber if you have more questions about how long Tysabri (natalizumab) stays in your body.
              Is Tysabri (natalizumab) a form of chemotherapy?
              No, Tysabri (natalizumab) isn't a form of chemotherapy. Chemotherapy is a type of treatment that kills all fast-growing cells in the body and is typically used to treat cancer. Instead, Tysabri (natalizumab) is a biologic called a monoclonal antibody. It treats CD and MS by specifically finding certain immune cells in the body and interfering with inflammatory signals.
              Is Tysabri (natalizumab) an immunosuppressant?
              Yes, Tysabri (natalizumab) can be considered an immunosuppressant because it's a medication that can weaken your immune system. This can put you at risk for infections.
              Who makes Tysabri (natalizumab)?
              Tysabri (natalizumab) is made by the manufacturing company called Biogen.
              What's the difference between Tysabri and Tyruko?
              Both Tysabri and Tyruko have the same active ingredient, natalizumab. But they aren't identical. Tyruko is a biosimilar to Tysabri that was FDA approved in August 2023. Tyruko works in the same way as Tysabri and both medications are expected to provide the same benefits. The main difference between them is that Tyruko is expected be lower in cost than Tysabri. But keep in mind that Tysabri and Tyruko aren't interchangeable. This means that you need a new prescription to switch from one to the other. Talk to your prescriber to learn more about the similarities and differences between the two medications.
              GoodRxEducationalIcon

              How to save using GoodRx

              Compare Prices
              1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
              Select your free coupon
              2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
              Show coupon to your pharmacist
              3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
              Get free couponLearn more
              warings-icon

              What are the risks and warnings for Tysabri (natalizumab)?

              Tysabri (natalizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

              risk-warning

              Progressive multifocal leukoencephalopathy (PML)

              • Risk factors: Having antibodies against the JC virus in the body | Taking Tysabri (natalizumab) for a long time (longer than 2 years) | Taking or have taken medications that weaken your immune system

                Tysabri (natalizumab) can make it harder for your body to fight off infections. In particular, it can raise your risk of developing a serious brain infection caused by the John Cummingham virus (JCV). This infection is called progressive multifocal leukoencephalopathy (PML). It can lead to death or severe disability in people with a weakened immune system, like those who take Tysabri (natalizumab).

                Get medical attention as soon as possible if you feel weak on one side of the body; feel clumsy; or notice changes in personality, vision, memory, or thinking skills. Continue to watch for these symptoms of PML for at least 6 more months after you stop taking Tysabri (natalizumab) because the infection can also appear after treatment ends. It's important to get help right away and get tested for PML since symptoms can worsen over days to weeks.

                Because of the risk for PML with Tysabri (natalizumab), you, your prescriber, and any place that dispenses or infuses the medication must be enrolled in the TOUCH Prescribing Program. This is a Risk Evaluation and Mitigation Strategies (REMS) program that makes sure that everyone involved in treatment is aware of the risks of the medication.

                risk-warning

                Other infections

                • Risk factors: Taking medications that weaken your immune system | Having a medical condition that weakens your immune system

                  Tysabri (natalizumab) can raise your risk for other infections caused by bacteria, viruses, or fungi. These infections can sometimes be serious. They can happen in different parts of your body, including the brain, eyes, lungs, stomach, and urinary tract. Let your care team know if you don't feel well or if you have any signs of an infection, like fevers, chills, tiredness, confusion, stomach aches, difficulty breathing, cough, or eye pain. If you get a serious infection while you're taking Tysabri (natalizumab), you might have to stop the medication so you can get appropriate treatment.

                  risk-warning

                  Liver problems

                  Some people taking Tysabri (natalizumab) developed liver damage. Sometimes, this led to life-threatening liver failure or the need for a transplant. Get medical attention right away if you feel tired or if you have poor appetite, discomfort in the upper right side of the stomach, dark urine, or yellowing of the skin or whites of your eyes. These can be symptoms of liver damage. Your prescriber might order blood tests to check your liver health. If you develop liver problems, you might need to stop Tysabri (natalizumab) to prevent more damage.

                  risk-warning

                  Allergic reaction or infusion reaction

                  • Risk factors: Having antibodies to Tysabri (natalizumab) in the body | Restarting Tysabri (natalizumab) after a long break

                    Allergic reactions, including infusion reactions, are possible while you're taking Tysabri (natalizumab). In rare cases, the allergic reaction can be very serious and sometimes life-threatening, like with anaphylaxis. The risk for allergic reactions might be higher if your body has made antibodies against the medication. Your prescriber might order blood tests every few months to check for these antibodies.

                    Allergic reactions can typically happen within 2 hours after the Tysabri (natalizumab) infusion starts. The healthcare professional will watch out for reactions during your infusion and also for a period of time afterwards.

                    Still, it's important to be aware of symptoms of an allergic reaction or an infusion reaction. These can include hives, rash, itching, dizziness, fever, shivering, flushing, shortness of breath, chest pain, and nausea. Get medical help right away if any of these symptoms appear. The healthcare professional will stop the infusion and help manage your symptoms. It's possible that you might need to stop taking Tysabri (natalizumab) altogether.

                    risk-warning

                    Low platelet levels

                    Some people who took Tysabri (natalizumab) developed low platelet levels during treatment. Platelets are cells in your blood that help stop bleeding when you get injured, like when you get a cut. Having platelet levels that are too low can put you at risk for bleeding.

                    Contact your care team right away if you notice any bleeding that's difficult to stop, easy bruising, or red or purple pinpoint spots on your skin. Your care team can examine you. You might need to stop Tysabri (natalizumab) if your platelet levels are too low.

                    dosage

                    Tysabri (natalizumab) dosage forms

                    Typical dosing for Tysabri (natalizumab)

                    The typical dose is 300 mg infused into the vein (IV) once per month. The IV infusion is given by a healthcare professional at a medical office, hospital, or infusion center.

                    More on Tysabri (natalizumab) dosage forms

                    interactions

                    Interactions between Tysabri (natalizumab) and other drugs

                    Tysabri (natalizumab) may interact with certain medications or supplements. Always let your doctor and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking. The list below does not include all possible drug interactions with Tysabri (natalizumab). Please note that only the generic name of each medication is listed below.

                    Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

                    Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

                    contraindications-icon

                    Tysabri (natalizumab) contraindications

                    Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Tysabri (natalizumab) will not be safe for you to take.
                    alternatives

                    What are alternatives to Tysabri (natalizumab)?

                    There are a number of medications that your doctor can prescribe in place of Tysabri (natalizumab). Compare a few possible alternatives below.
                    Tysabri (natalizumab)
                    Used for:
                    Used for:
                    • Relapsing forms of multiple sclerosis (MS)

                    $1470.01 Lowest GoodRx priceView Prices
                    latest news

                    What is the latest news about Tysabri (natalizumab)?

                    Get savings updates for Tysabri (natalizumab)

                    Receive price alerts, news, and other messages from GoodRx about Tysabri (natalizumab) and other healthcare topics and relevant savings offers.

                    By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                    References

                    Best studies we found

                    American Cancer Society. (2019). How is chemotherapy use to treat cancer?

                    Biogen. (n.d.). The Touch Prescribing Program.

                    Biogen. (2023). Overview of the TOUCH Program.

                    View All References (10)

                    Biogen Inc. (2024). Tysabri- natalizumab injection [package insert]. DailyMed.

                    Butzkueven, H., et al. (2020). Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). Journal of Neurology, Neurosurgery, and Psychiatry.

                    Drugs and Lactation Database (LactMed®). (2024). Natalizumab. National Institute of Child Health and Human Development.

                    Friend, S., et al. (2016). Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: A global, observational, follow-up study. BioMed Central Neurology.

                    Kawamoto, E., et al. (2012). Anti-integrin therapy for multiple sclerosis. Autoimmune Diseases.

                    McLean, L. P., et al. (2016). Integrin antagonists as potential therapeutic options for the treatment of Crohn's disease. Expert Opinion on Investigational Drugs.

                    National Human Genome Research Institute. (2024). Antibody.

                    National Institute of Neurological Disorders and Stroke. (2024). Progressive multifocal leukoencephalopathy.

                    Sandoz Inc. (2023). Tyruko (natalizumab-sztu) injection, for intravenous use [package insert].

                    Selewski, D. T., et al. (2010). Natalizumab (Tysabri). American Journal of Neuroradiology.

                    GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                    Was this page helpful?

                    Browse medications

                    View All

                    Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.